Table 2 Reduction of mean systolic blood pressure values at 6 and 12 weeks for each dose of olmesartan and amlodipine FDC
From: Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
Olmesartan and amlodipine doses | Baseline (mean ± SD) | 6 weeks (mean ± SD) | Difference initial/6 weeks (mean ± SD) | p | 12 weeks (mean ± SD) | Difference initial/12 weeks (mean ± SD) | p |
|---|---|---|---|---|---|---|---|
20/5 mg (N = 183 patients) | 157 ± 16.28 | 138.45 ± 14.10 | 18.76 ± 21.72 | <0.001 | 129.24 ± 12.92 | 27.75 ± 20.73 | <0.001 |
40/5 mg (N = 198 patients) | 161.93 ± 17.92 | 140.85 ± 14.04 | 20.83 ± 22.64 | <0.001 | 130.79 ± 10.77 | 31.13 ± 22.23 | <0.001 |
40/10 mg (N = 47 patients) | 176.46 ± 18.68 | 140 ± 12.88 | 36.68 ± 21.87 | <0.001 | 129.5 ± 12.40 | 46.96 ± 20.15 | <0.001 |